VisEn Medical Inc.

VisEn Medical Inc. of Woburn, Mass., has announced a research collaboration with Merck & Co. Inc. of Whitehouse Station, N.J. Under the terms of the agreement, the partners will develop biomarkers for Merck to use in its drug discovery programs to study disease progression and therapeutic response. Fluorescence molecular tomography systems from VisEn will be used for analysis. The Massachusetts company also will commercialize technologies resulting from the partnership.





LATEST NEWS

• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024
• CLEO Heads to the East Coast
  Apr 29, 2024
• Qubits Could be Stored in Flash-Like Memory
  Apr 29, 2024